1. Home
  2. BIO vs KEP Comparison

BIO vs KEP Comparison

Compare BIO & KEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • KEP
  • Stock Information
  • Founded
  • BIO 1952
  • KEP 1961
  • Country
  • BIO United States
  • KEP South Korea
  • Employees
  • BIO N/A
  • KEP N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • KEP Electric Utilities: Central
  • Sector
  • BIO Industrials
  • KEP Utilities
  • Exchange
  • BIO Nasdaq
  • KEP Nasdaq
  • Market Cap
  • BIO 8.7B
  • KEP 9.4B
  • IPO Year
  • BIO N/A
  • KEP N/A
  • Fundamental
  • Price
  • BIO $320.44
  • KEP $8.37
  • Analyst Decision
  • BIO Buy
  • KEP
  • Analyst Count
  • BIO 4
  • KEP 0
  • Target Price
  • BIO $369.00
  • KEP N/A
  • AVG Volume (30 Days)
  • BIO 218.2K
  • KEP 115.5K
  • Earning Date
  • BIO 10-24-2024
  • KEP 09-24-2024
  • Dividend Yield
  • BIO N/A
  • KEP N/A
  • EPS Growth
  • BIO N/A
  • KEP N/A
  • EPS
  • BIO N/A
  • KEP 3.00
  • Revenue
  • BIO $2,562,604,000.00
  • KEP $65,870,350,762.00
  • Revenue This Year
  • BIO N/A
  • KEP $5.48
  • Revenue Next Year
  • BIO $4.49
  • KEP $3.16
  • P/E Ratio
  • BIO N/A
  • KEP $5.46
  • Revenue Growth
  • BIO N/A
  • KEP 12.78
  • 52 Week Low
  • BIO $261.59
  • KEP $5.93
  • 52 Week High
  • BIO $384.37
  • KEP $9.55
  • Technical
  • Relative Strength Index (RSI)
  • BIO 50.24
  • KEP 63.61
  • Support Level
  • BIO $311.04
  • KEP $7.99
  • Resistance Level
  • BIO $337.50
  • KEP $8.39
  • Average True Range (ATR)
  • BIO 8.18
  • KEP 0.10
  • MACD
  • BIO -1.35
  • KEP -0.02
  • Stochastic Oscillator
  • BIO 43.70
  • KEP 63.93

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About KEP Korea Electric Power Corporation

Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment.

Share on Social Networks: